Therapeutic Efficacy of an Oncolytic Influenza Virus Carrying an Antibody Against Programmed Cell Death 1 in Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic Efficacy of an Oncolytic Influenza Virus Carrying an Antibody Against Programmed Cell Death 1 in Hepatocellular Carcinoma

Published:2022-03-01 Issue:5-6 Volume:33 Page:309-317
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Lei Guanglin¹,Li Baofa²,Yang Hao¹,Sun Fang¹,Li Donghui³,Yan Jin¹,Wang Yonggang¹,Li Ruisheng¹,Liu Honghong¹,Zhang Shaogeng¹,Li Yufeng⁴,Yang Penghui¹

Affiliation:

1. Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.

2. Department of Liver Disease Kaifeng Infectious Disease Hospital, Henan, China.

3. Fourth Medical Center of Chinese PLA General Hospital, Beijing, China.

4. First Medical Center of Chinese PLA General Hospital, Beijing, China.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/hum.2021.167

Reference22 articles.

1. Oncolytic viruses for cancer immunotherapy

2. Combination therapy with oncolytic viruses and immune checkpoint inhibitors

3. Oncolytic viruses: overcoming translational challenges

4. Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma

5. An Update on the Role of Talimogene Laherparepvec (T-VEC) in the Treatment of Melanoma: Best Practices and Future Directions

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy;Nature Protocols;2024-05-20

2. An Engineered Influenza a Virus Expressing the Co-Stimulator OX40L as an Oncolytic Agent Against Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2024-01

3. A recombinant oncolytic influenza virus expressing a PD-L1 antibody induces CD8+ T-cell activation via the cGas-STING pathway in mice with hepatocellular carcinoma;International Immunopharmacology;2023-07

4. Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cells;Clinical and Experimental Medicine;2023-02-11

5. Research Progress of Oncolytic Influenza Virus;PROG BIOCHEM BIOPHYS;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3